MarketPeel
Insider Trading Intelligence
EK

Emil Kuriakose

TERN
CHIEF MEDICAL OFFICER · TERNS PHARMACEUTICALS, INC. · CIK 0001892413
FILING MIX · LIFETIME22%/78%
BUYS
4
SELLS
14
TOTAL VALUE
$5.78M
COMPANIES
1
ACTIVE SINCE
Dec 2024
HOLDINGS NOW
0
AVG SELL PX
$49.88
TRADE KIND
SHOWING 18 / 18
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizons · 12 pending
Forward-return performance of every backtestable P/S trade by Emil Kuriakose, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+71.43%-3.90%-0.45%-3.45%-8.32%
14d7+71.43%-0.65%+0.94%-1.59%-6.97%
30d7+42.86%+8.40%+2.92%+5.48%-9.72%
60d7+16.67%+53.59%+1.72%+51.87%+10.16%
90d7+16.67%+95.76%+3.19%+94.22%+35.50%
180d7(1 pending)+25.00%+431.80%+8.13%+424.25%+384.26%
1y7(4 pending)+0.00%+1284.76%+18.30%+1267.75%+1267.75%
2y7(7 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TERN · 0 shares · as of May 5, 2026
0121,250242,500363,750485,00020252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2025
2025
2025
2025
2026
2026
FLOW · 4 buys / 14 sellsCOVERAGE · 7 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TERN
TERNS PHARMACEUTICALS, INC.
SALE
Chief Medical Officer
81,953$53.00$4.34M0May 5, 2026May 5, 2026View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
Chief Medical Officer
280,0000May 5, 2026May 5, 2026View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
Chief Medical Officer
112,5000May 5, 2026May 5, 2026View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
Chief Medical Officer
24,562$53.00$1.30M0May 5, 2026May 5, 2026View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
Chief Medical Officer
117,5000May 5, 2026May 5, 2026View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
Chief Medical Officer
120,0000May 5, 2026May 5, 2026View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
Chief Medical Officer
485,0000May 5, 2026May 5, 2026View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
Chief Medical Officer
942$52.75$49.7K105,673Apr 1, 2026Apr 2, 2026View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
56,250106,615Jan 14, 2026Jan 16, 2026View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
112,500112,500Jan 14, 2026Jan 16, 2026View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
Chief Medical Officer
200$39.60$7.9K51,320Jan 2, 2026Jan 6, 2026View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
Chief Medical Officer
955$38.36$36.6K50,365Jan 2, 2026Jan 6, 2026View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
Chief Medical Officer
944$7.85$7.4K51,520Oct 1, 2025Oct 2, 2025View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
Chief Medical Officer
853$4.27$3.6K52,464Jul 1, 2025Jul 3, 2025View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
Chief Medical Officer
952$2.49$2.4K53,317Apr 1, 2025Apr 2, 2025View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
485,000485,000Jan 30, 2025Feb 3, 2025View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
Chief Medical Officer
4,481$5.71$25.6K54,269Jan 2, 2025Jan 6, 2025View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
120,000120,000Dec 12, 2024Dec 16, 2024View →
Other insiders · TERN
Loading peer insiders…
About this filer
CIK 0001892413
ROLE
Chief Medical Officer
PRIMARY
TERN
COMPANIES
1
ACTIVE SINCE
Dec 2024
MARKETPEEL · /INSIDER/0001892413DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback